Investor Contacts: ACADIA Pharmaceuticals Inc. Steve Davis, Interim Chief Executive Officer Lisa Barthelemy, Director of Investor Relations (858) 558-2871 or Media Contact: Russo Partners David Schull (858) 717-2310 [email protected]
Date: Mar 11, 2015
Category: Business
Source: Google
Obesity Prompts Vivus Takeover Talk With 88% Windfall: Real M&A
Arena is focused on preparing for its FDA advisory committee meeting in the second quarter, David Schull, an outside spokesman for the company, said in an e-mail. He declined to comment further.
Date: Feb 29, 2012
Category: Health
Source: Google
Orexigen Falls After Halting Development of Diet Pill in U.S.
chief financialofficer, in an e-mailed statement. Arena, which is developing amedicine called lorcaserin with Tokyo-based Eisai Co., is alsomoving forward to do whats needed to bring its drug topatients, said David Schull, an outside spokesman for thecompany, in an e-mail today.
David Schull (1990-1993), Kim Baumann (1988-1991), Shelia Ford (1996-1998), Cynthia Williams (1983-1986), Christopher Haney (1996-1999), Tina Bradford (1991-1993)